Skip to main content
. 2001 Nov;67(11):5032–5036. doi: 10.1128/AEM.67.11.5032-5036.2001

FIG. 3.

FIG. 3

Immunoblots obtained with 200 ng of purified Cry1Ab3 toxin (lanes 6, 9, and 10), 500 ng of purified Cry1Ca1 toxin (lanes 1, 4, 5, and 8), and a mixture of the Cry1Ca1 and Cry1Da1 toxins (500 ng) from purified inclusions from strain #5 (lanes 2, 3, and 7). Lanes 1 and 2 were treated with Cry1Da antibody, lanes 3 to 6 were treated with Cry1Ca1 antibody, and lanes 7 to 10 were treated with Cry1Ab3 antibody.